GENSCRIPT BIO (01548) fell more than 4% against the market trend, dropping 4.25% to HKD 16.43 by the time of writing, with a turnover of HKD 221 million.

On the news front, on the evening of November 12, Legend Biotech, an associate company of GENSCRIPT BIO, disclosed its financial results for the third quarter ended September 30, 2025. The financial data showed a net loss of $39.7 million for the three months ended September 30, 2025, compared to a net loss of $125.3 million in the same period last year. The adjusted net loss stood at $18.8 million, narrowing from an adjusted net loss of $42 million in the prior-year period.